Next Generation Biofactories

Courtesy James Weaver and Daniel Morse  These starburst structures of silica are produced as a rudimentary form of skeletal support by the sponge Tethya aurantia found in shallow waters off California. Yeast, diatoms, sponges: Already occupying mundane places in modern households, these organisms may yet inspire important new manufacturing developments. From minute and intricate computer chip components, to nanoscale gold-plated wires, to superior drug manufacturing capabilities, univers

Written byHarvey Black
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Yeast, diatoms, sponges: Already occupying mundane places in modern households, these organisms may yet inspire important new manufacturing developments. From minute and intricate computer chip components, to nanoscale gold-plated wires, to superior drug manufacturing capabilities, university researchers and companies are exploring ways to manipulate and harness these organisms' natural abilities.

"I really think this is intellectually challenging, to think of how you could build something with specific properties ... by taking advantage of what evolution has built into proteins. It's fascinating," says Susan Lindquist, director of the Whitehead Institute for Biomedical Research in Cambridge, Mass. "It forces you to think in ways you hadn't thought before." Lindquist made her comments at a conference featuring hers and others' work.

For diatoms and sponges, the industrial promise lies in their ability to use silicic acid (the common form of silicon) to make exquisite silica skeletal structures. "What has been a mystery for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies